Allergan, is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live good life.
Company Growth (employees)
Type
Public
HQ
Dublin, IE
Founded
1948
Size (employees)
16,700 (est)-46%
Allergan was founded in 1948 and is headquartered in Dublin, IE

Key People/Management at Allergan

Robert Stewart

Robert Stewart

Chief Operating Officer
Brenton Saunders

Brenton Saunders

Chairman of the Board of Directors, Chief Executive Officer and President
William Meury

William Meury

Chief Commercial Officer

Allergan Office Locations

Allergan has offices in Dublin and Parsippany-Troy Hills
Parsippany-Troy Hills, US
400 Interpace Pkwy

Allergan Financials and Metrics

Allergan Financials

USD

Market capitalization (31-Oct-2017)

59.3 b

Closing share price (31-Oct-2017)

178.6

Cash (31-Dec-2014)

4.9 b

EV

56.5 b
Allergan's current market capitalization is $59.3 b.
USDFY, 2013FY, 2014

Cash

3 b4.9 b

Accounts Receivable

883.3 m914.5 m

Inventories

285.3 m296 m

Current Assets

5.3 b6.9 b
USDFY, 2013FY, 2014

Net Income

988.7 m1.5 b

Depreciation and Amortization

254.6 m248.1 m

Inventories

(27 m)(44 m)

Accounts Payable

37.4 m1.9 m
Y, 2014

EV/CFO

29.3 x

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

1.6 x
Show all financial metrics

Allergan Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
ZELTIQ Aesthetics (CoolSculpting)February 15, 2017$2.5 b

Allergan Market Value History

Allergan Median Salaries

Source: 108 public H-1B filings from Allergan

Allergan's Web-traffic and Trends

Allergan Online and Social Media Presence

Allergan News and Updates

Insider trading case against Ackman, Valeant approaches trial: report

Valeant and former activist partner Bill Ackman may once again be thwarted in their efforts to get insider trading claims against them tossed.

The Bill Ackman problem everyone forgot is now at threat-level substantial

The insider trading case against Pershing Square founder Bill Ackman and Valeant Pharmaceuticals may go to trial. Investors in Allergan Pharmaceuticals are suing Ackman and Valeant over their hostile takeover of the company in 2014. There may be a Bill Ackman insider-trading trial on the way. Yo…

Settle down, Allergan investors. Botox's market share is safe, analysts say

Allergan’s investors fretted Tuesday over strong data from a potential Botox competitor. But the way analysts see it, there’s not much to worry about.

EMA investigates Allergan blockbuster hopeful Esmya on reports of liver damage

As Allergan chases a U.S. approval for uterine fibroids drug Esmya, across the pond, regulators are investigating the treatment for liver damage.

Tech firms tell patent court to ignore Allergan deal with tribe

(Reuters) - Over 30 technology companies including Alphabet Inc , Amazon.com Inc and Facebook Inc. on Friday urged a U.S. patent court to disregard drugmaker Allergan Plc's contention that its transfer of some of its patents to a Native American tribe shields them from the court's review.

Tech firms tell patent court to ignore Allergan deal with tribe

(Reuters) - Over 30 technology companies including Alphabet Inc , Amazon.com Inc and Facebook Inc. on Friday urged a U.S. patent court to disregard drugmaker Allergan Plc's contention that its transfer of some of its patents to a Native American tribe shields them from the court's review.
Show more

Allergan Company Life and Culture

You may also be interested in